121 related articles for article (PubMed ID: 3498039)
1. Finger joint calcinosis followed by osteolysis in a patient with multisystem connective tissue disease and anti-Jo-1 antibody.
Cohen MG; Ho KK; Webb J
J Rheumatol; 1987 Jun; 14(3):605-8. PubMed ID: 3498039
[TBL] [Abstract][Full Text] [Related]
2. Anti-Jo-1 antibody-positive arthropathy presenting as severe osteolysis of the distal interphalangeal joints.
Yamamoto M; Harada S; Ohara M; Suzuki C; Naishiro Y; Yamamoto H; Takahashi H; Takahashi H; Imai K
Rheumatology (Oxford); 2005 Feb; 44(2):218. PubMed ID: 15681338
[No Abstract] [Full Text] [Related]
3. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
5. Benign hypergammaglobulinemic purpura and anti-Ro(SSA) antibodies in undifferentiated connective tissue disease.
Caporali R; Scatola C; Montecucco C
J Rheumatol; 1996 Feb; 23(2):410-1. PubMed ID: 8882066
[No Abstract] [Full Text] [Related]
6. [Preliminary report on the clinical application of anti-Jo-1 antibody].
Dong Y; Cheng PC; Zhang NC
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):368-9, 383. PubMed ID: 2582917
[TBL] [Abstract][Full Text] [Related]
7. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis.
Oddis CV; Medsger TA; Cooperstein LA
Arthritis Rheum; 1990 Nov; 33(11):1640-5. PubMed ID: 2242062
[TBL] [Abstract][Full Text] [Related]
8. [Anti-nucleolar antibodies in patients with connective tissue disease].
Tanaka M
Ryumachi; 1984 Jun; 24(3):173-82. PubMed ID: 6209811
[No Abstract] [Full Text] [Related]
9. Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis. Expanding the clinical spectrum of the antisynthetase syndrome.
Queiro-Silva R; Bañegil I; de Dios-Jiménez de Aberásturi JR; Belzunegui-Otano J; González-Beneitez C; Figueroa-Pedrosa M
J Rheumatol; 2001 Jun; 28(6):1401-4. PubMed ID: 11409138
[TBL] [Abstract][Full Text] [Related]
10. [Clinical importance of antinuclear antibodies].
Dabelić N; Cikes N
Lijec Vjesn; 1997; 119(8-9):236-42. PubMed ID: 9481891
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of antibodies against extractible nuclear antigens (ENA) with a view to "mixed connective tissue syndrome" (author's transl)].
Zitnan D; Cebecauer L; Miceková D; Lukác J; Rovenský J; Tauchmannová H
Cas Lek Cesk; 1980; 119(8):227-33. PubMed ID: 6966537
[No Abstract] [Full Text] [Related]
12. [Antinuclear antibodies, anti-SSA(Ro) and SSB(La) in diffuse connective tissue diseases].
Assad RL; Gabriel Júnior A; Iglesias SS; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):103-8. PubMed ID: 3551017
[No Abstract] [Full Text] [Related]
13. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
14. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy.
Bruze M; Krook G; Ljunggren B
Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of antinuclear and anti-native-DNA antibodies in connective tissue diseases].
Guzmán L; González C; Arriagada M; Grisanti M; Meléndez M; Arinoviche R
Rev Med Chil; 1982 Jan; 110(1):24-8. PubMed ID: 6760312
[No Abstract] [Full Text] [Related]
16. [Antibodies to soluble nuclear antigens and native DNA in patients with connective tissue diseases with antinuclear antibodies].
Damilano G; Hübscher O; Fernández L; Arana RM
Medicina (B Aires); 1983; 43(5):488-94. PubMed ID: 6371438
[No Abstract] [Full Text] [Related]
17. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
Benhamou CL; Amor B; Menkes CJ; Delbarre F
Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281
[TBL] [Abstract][Full Text] [Related]
18. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
19. [Antinuclear antibodies in rheumatology].
Zuber M
Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
[TBL] [Abstract][Full Text] [Related]
20. Anti-Jo-1 antibodies.
Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
